GLP-1 receptor agonists and cardiovascular risk in routine clinical practice.

Lancet Diabetes Endocrinol · 2019

Last updated 2026-05-28

Journal	Lancet Diabetes Endocrinol, 2019
Citations	1
Relative citation ratio	0.03
NIH percentile	4
Molecules	—
Conditions studied	Cardiovascular Risk Reduction

Full record and abstract on PubMed 30527908 ↗